Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression

Psychiatry and Clinical Neurosciences

Volumn 60, Issue 6, 2006, Pages 746-750

  Hsiao, Cheng Cheng ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anxiety severity; Depression severity; DHEAS; Hamilton depression score; Hospital Anxiety and Depression Scale

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; HAMILTON SCALE; HUMAN; MALE; SEX RATIO; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGING; ANXIETY; BODY MASS INDEX; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TAIWAN;

EID: 33750947320     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2006.01590.x     Document Type: Article

References (33)

1. Chengcheng H. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores. Psychoneuroendocrinology 2006; 31: 839-846.
2. Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 169-192.
3. Chengcheng H, Chiayih L, Meichun H. No correlation of depression and anxiety to plasma estrogen and progesterone level in patients with premenstrual dysphoric disorder. Psychiatry Clin. Neurosci. 2004; 58: 601-607.
4. Meichun H, Chengcheng H, Chiayih L. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin. Neurosci. 2004; 58: 186-190.
5. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl Acad. Sci. USA 1981; 78: 4704-4707.
6. Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 1996; 150: 221-239.
7. A receptor, mechanism of action and physiological significance. Prog. Neurobiol. 1992; 38: 379-395.
8. Majewska MD. Neuronal actions of the dehydroepiandrosterone. Possible roles in brain development, aging, memory and affect. Ann. NY Acad. Sci. 1995; 774: 111-120.
9. Spivak B, Maayan R, Kotler M et al. Elevated circulatory level of GABA (A)-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med. 2000; 30: 1227-1231.
10. Rosenfeld RS, Hellman L, Roffwarg H, Weitzman ED, Fukushima DK, Gallagher TF. Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J. Clin. Endocrinol. 1971; 33: 87-92.
11. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J. Clin. Pharmacol. 1999; 39: 327-348.
12. Osmanagaoglu MA, Okumus B, Osmanagaoglu T, Bozkaya H. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J. Womens Health 2004; 13: 993-999.
13. Maayan R, Morad O, Dorfman P, Overstreet DH, Weizman A, Yadid G. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression. Eur. Neuropsychopharmacol. 2005; 15: 253-262.
14. Bailey J, Coppen A. A comparison between the Hamilton Rating Scale and the Beck Inventory in the measurement of depression. Br. J. Psychiatry 1976; 128: 486-489.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC, 1994.
16. Sheehan DV, Lecrubier Y, Sheehan KH. The Mini-International Neuropsychiatric Interview (MINI). The development and validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998; 59: 22-33.
17. Leung CM, Ho S, Kan CS, Hung CH, Chen CN. Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int. J. Psychosom. 1993; 40: 29-34.
18. Maayan R, Strous RD, Abou-Kaoud M, Weizman A. The effect of 17-beta estradiol withdrawal on the level of brain and peripheral neurosteroids in ovarectomized rats. Neurosci. Lett. 2005; 384: 156-161.
19. Paoletti AM, Lello S, Fratta S et al. Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol. Fertil. Steril. 2004; 81: 645-651.
20. Imamura M, Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem. Biophys. Res. Commun. 1998; 243: 771-775.
21. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 2005; 180: 267-278.
22. Yaffe K, Ettinger B, Pressman A. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry 1998; 43: 694-700.
23. Barrett-Connor E, von Muhlen D, Laughlin GA. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 1999; 47: 685-691.
24. T'Sjoen GG, De Vos S, Goemaere S et al. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J. Am. Geriatr. Soc. 2005; 53: 636-642.
25. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu EE. Dehydroepiandrosterone sulfate in a longterm care aged population. Gerontology 1995; 41: 343-351.
26. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl Acad. Sci. USA 1996; 93: 13410-13415.
27. Sulcová J, Hill M, Hampl R, Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J. Endocrinol. 1997; 154: 57-62.
28. Wolf OT, Krischbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Rev. 1999; 30: 264-288.
29. Pasquali R, Ambrosi B, Armanini D et al. Study Group on Obesity of the Italian Society of Endocrinology. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J. Clin. Endocrinol. Metab. 2002; 87: 166-175.
30. Key TJ, Pike MC, Baron JA et al. Cigarette smoking and steroid hormones in women. J. Steroid. Biochem. Mol. Biol. 1991; 39: 529-534.
31. Copp JE, Schwiderski UE, Robinson DS. Symptom comorbidity in anxiety and depressive disorders. J. Clin. Psychopharmacol. 1990; 10 (3 Suppl.): 52S-60S.
32. Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing body weight predicts the earlier onset of insulin-dependent diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet. Med. 2005; 22: 144-151.
33. Ferrari E, Mirani M, Barili L et al. Cognitive and affective disorders in the elderly: a neuroendocrine study. Arch. Gerontol. Geriatr. 2004; (Suppl. 9): 171-182.